Catalyst Wire Dossier Catalyst Wire Dossier

IgM-enriched intravenous immunoglobulin (IVIG) therapy

IgM-enriched intravenous immunoglobulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IgM-enriched intravenous immunoglobulin (IVIG) therapy, covering 2018-04-24 to 2018-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Immunglobulin M Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients

See pricing